Literature DB >> 11095159

Hypertension and the prothrombotic state.

G Y Lip1.   

Abstract

The basic underlying pathophysiological processes underlying the major complications of hypertension (that is, heart attacks and strokes) are thrombogenesis and atherogenesis. Indeed, despite the blood vessels being exposed to high pressures in hypertension, the complications of hypertension are paradoxically thrombotic in nature rather than haemorrhagic. The evidence suggests that hypertension appears to confer a prothrombotic or hypercoagulable state, which can be related to conventional risk factors, target organ damage, complications and long-term prognosis, as well as different antihypertensive treatments. Further work is needed to examine the mechanisms leading to this phenomenon, the potential prognostic and treatment implications, and the possible value of measuring these parameters in routine clinical practice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11095159     DOI: 10.1038/sj.jhh.1001051

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  19 in total

Review 1.  Hypertension, left ventricular hypertrophy, and sudden death.

Authors:  Lwin Lwin Tin; D Gareth Beevers; Gregory Y H Lip
Journal:  Curr Cardiol Rep       Date:  2002-11       Impact factor: 2.931

2.  A cluster of blood-based protein biomarkers reflecting coagulation relates to the burden of cerebral small vessel disease.

Authors:  Sanne Kuipers; L Malin Overmars; Bram van Es; Jeroen de Bresser; Esther E Bron; Imo E Hoefer; L Jaap Kappelle; Charlotte E Teunissen; Geert Jan Biessels; Saskia Haitjema
Journal:  J Cereb Blood Flow Metab       Date:  2022-01-27       Impact factor: 6.960

3.  Circulating levels of cell adhesion molecules in hypertension.

Authors:  Kavita K Shalia; Manoj R Mashru; Jagdish B Vasvani; Rajashree A Mokal; Shilpa M Mithbawkar; Priti K Thakur
Journal:  Indian J Clin Biochem       Date:  2009-12-30

4.  Roles of Coagulation and fibrinolysis in angiotensin II-enhanced microvascular thrombosis.

Authors:  Elena Y Senchenkova; Janice Russell; Charles T Esmon; D Neil Granger
Journal:  Microcirculation       Date:  2014-07       Impact factor: 2.628

5.  CD39/NTPDase-1 activity and expression in normal leukocytes.

Authors:  E Dianne Pulte; M Johan Broekman; Kim E Olson; Joan H F Drosopoulos; Jorge R Kizer; Naziba Islam; Aaron J Marcus
Journal:  Thromb Res       Date:  2007-06-07       Impact factor: 3.944

Review 6.  Three decades of research on angiogenin: a review and perspective.

Authors:  Jinghao Sheng; Zhengping Xu
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2015-12-23       Impact factor: 3.848

7.  Arterial Hypertension Is Characterized by Imbalance of Pro-Angiogenic versus Anti-Angiogenic Factors.

Authors:  Natalia Marek-Trzonkowska; Anna Kwieczyńska; Magdalena Reiwer-Gostomska; Tomasz Koliński; Andrzej Molisz; Janusz Siebert
Journal:  PLoS One       Date:  2015-05-07       Impact factor: 3.240

Review 8.  The burden of uncontrolled hypertension: morbidity and mortality associated with disease progression.

Authors:  William C Cushman
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 May-Jun       Impact factor: 3.738

9.  The interaction of vasoactive substances during exercise modulates platelet aggregation in hypertension and coronary artery disease.

Authors:  Konstantinos Petidis; Stella Douma; Michael Doumas; Ilias Basagiannis; Konstantinos Vogiatzis; Chrysanthos Zamboulis
Journal:  BMC Cardiovasc Disord       Date:  2008-05-27       Impact factor: 2.298

10.  Prevalence and Aetiology of Left Ventricular Thrombus in Patients Undergoing Transthoracic Echocardiography at the University of Maiduguri Teaching Hospital.

Authors:  Mohammed Abdullahi Talle; Faruk Buba; Charles Oladele Anjorin
Journal:  Adv Med       Date:  2014-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.